Suppr超能文献

实体瘤转移性癌症患者生命最后 2 年的医疗费用轨迹:一项前瞻性队列研究。

Healthcare Cost Trajectories in the Last 2 Years of Life Among Patients With a Solid Metastatic Cancer: A Prospective Cohort Study.

机构信息

Lien Centre for Palliative Care.

Program in Health Services and Systems Research, and.

出版信息

J Natl Compr Canc Netw. 2022 Sep;20(9):997-1004.e3. doi: 10.6004/jnccn.2022.7038.

Abstract

BACKGROUND

Most studies describe the "average healthcare cost trend" among patients with cancer. We aimed to delineate heterogeneous trajectories of healthcare cost during the last 2 years of life of patients with a metastatic cancer and to assess the associated sociodemographic and clinical characteristics and healthcare use.

PATIENTS AND METHODS

We analyzed a sample of 353 deceased patients from a cohort of 600 with a solid metastatic cancer in Singapore, and we used group-based trajectory modeling to identify trajectories of total healthcare cost during the last 2 years of life.

RESULTS

The average cost trend showed that mean monthly healthcare cost increased from SGD $3,997 during the last 2 years of life to SGD $7,516 during the last month of life (USD $1 = SGD $1.35). Group-based trajectory modeling identified 4 distinct trajectories: (1) low and steadily decreasing cost (13%); (2) steeply increasing cost in the last year of life (14%); (3) high and steadily increasing cost (57%); and (4) steeply increasing cost before the last year of life (16%). Compared with the low and steadily decreasing cost trajectory, patients with private health insurance (β [SE], 0.75 [0.37]; P=.04) and a greater preference for life extension (β [SE], -0.14 [0.07]; P=.06) were more likely to follow the high and steadily increasing cost trajectory. Patients in the low and steadily decreasing cost trajectory were most likely to have used palliative care (62%) and to die in a hospice (27%), whereas those in the steeply increasing cost before the last year of life trajectory were least likely to have used palliative care (14%) and most likely to die in a hospital (75%).

CONCLUSIONS

The study quantifies healthcare cost and shows the variability in healthcare cost trajectories during the last 2 years of life. Policymakers, clinicians, patients, and families can use this information to better anticipate, budget, and manage healthcare costs.

摘要

背景

大多数研究描述了癌症患者的“平均医疗保健成本趋势”。我们旨在描绘出晚期转移性癌症患者在生命的最后 2 年中医疗保健成本的异质轨迹,并评估相关的社会人口统计学和临床特征以及医疗保健的使用情况。

患者和方法

我们分析了新加坡一个 600 名实体转移性癌症队列中 353 名已故患者的样本,并使用基于群组的轨迹建模来确定生命最后 2 年中总医疗保健成本的轨迹。

结果

平均成本趋势表明,生命最后 2 年中,每月医疗保健费用从 SGD$3997 增加到生命最后一个月的 SGD$7516(USD$1=SGD$1.35)。基于群组的轨迹建模确定了 4 个不同的轨迹:(1)低且稳步下降的成本(13%);(2)生命最后一年急剧增加的成本(14%);(3)高且稳步增加的成本(57%);和(4)生命最后一年之前急剧增加的成本(16%)。与低且稳步下降的成本轨迹相比,有私人医疗保险(β[SE],0.75[0.37];P=.04)和更倾向于延长生命(β[SE],-0.14[0.07];P=.06)的患者更有可能遵循高且稳步增加的成本轨迹。处于低且稳步下降成本轨迹的患者最有可能接受姑息治疗(62%)并在临终关怀中心死亡(27%),而处于生命最后一年之前急剧增加成本轨迹的患者最不可能接受姑息治疗(14%),且最有可能在医院死亡(75%)。

结论

本研究量化了医疗保健成本,并显示了生命的最后 2 年中医疗保健成本轨迹的可变性。政策制定者、临床医生、患者和家属可以使用这些信息更好地预测、预算和管理医疗保健成本。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验